Lv32
260 积分 2024-10-21 加入
KRAS G12C mutation in metastatic colorectal cancer: a new target
25天前
已关闭
KRAS G12C mutation in metastatic colorectal cancer: a new target
25天前
已关闭
Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies
1个月前
已完结
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine
1个月前
已完结
Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients
1个月前
已完结
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer
1个月前
已完结
The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?
1个月前
已完结
Targeting Mutated KRAS Genes to Treat Solid Tumours
1个月前
已完结
Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directions
1个月前
已完结
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
